PT
Prelude Therapeutics Inc
🇺🇸XNAS.PRLDUnited StatesHealthcare
$4.47USDdown -0.12 (-2.61%)OpenEnd of day2:24 PM
Price$4.47-0.12 (-2.61%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US74065P1012
- CUSIP
- 74065P101
Company
- Employees
- 79
- Headquarters
- Wilmington, United States
- Website
- https://preludetx.com
- CEO
- Dr. Krishna Vaddi D.V.M., Ph.D.
Market
- Shares outstanding
- 64.9M
- Market cap
- $290.89M
Highlights
- Market cap
- $290.89M
- EPS LTM
- -$0.61
- P/E LTM
- -8.67
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $22.42M+220.34%up year on year
- Net income
- -$60.49M+51.34%up year on year
- Gross margin
- 94.5%+26.28%up year on year
- Free cash flow
- -$33.26M+69.36%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.